Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC

BACKGROUND: Adjuvant chemotherapy improves survival in patients with completely resected stage II and III NSCLC. However, its role in patients with stage IB NSCLC disease remains unclear. We evaluated the role of adjuvant chemotherapy in a large data set of patients with completely resected T2N0M0 N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Morgensztern, Daniel, Du, Lingling, Waqar, Saiama N., Patel, Aalok, Samson, Pamela, Devarakonda, Siddhartha, Gao, Feng, Robinson, Cliff G., Bradley, Jeffrey, Baggstrom, Maria, Masood, Ashiq, Govindan, Ramaswamy, Puri, Varun
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5141602/
https://ncbi.nlm.nih.gov/pubmed/27287414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.05.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados